Metraipolis › archive › dc_f48ce7bb6f62
Nanotechnology-Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives — Europe PMC PMID:40682256
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40682256
- DOI
- 10.1111/1759-7714.70134
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-07T19:07:27.226Z
- SHA-256 of the archived text
2ab78dfbb0877709958a0e3f3bd9c51758e735ac0c771c92c4d33840e5bb19fc- Stable URL of this page
https://metraipolis.com/documento/dc_f48ce7bb6f62
How to cite
Nanotechnology-Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives — Europe PMC PMID:40682256 — Europe PMC (en), https://europepmc.org/article/MED/40682256 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f48ce7bb6f62 (Metraipolis archive dc_f48ce7bb6f62, sha256 2ab78dfbb0877709958a0e3f3bd9c51758e735ac0c771c92c4d33840e5bb19fc)
BibTeX
@misc{dcf48ce7bb6f62,
title = {Nanotechnology-Driven Drug Delivery Systems for Lung Cancer: Computational Advances and Clinical Perspectives — Europe PMC PMID:40682256},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40682256},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f48ce7bb6f62; sha256 2ab78dfbb0877709958a0e3f3bd9c51758e735ac0c771c92c4d33840e5bb19fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40682256. Agents can read the archived copy with the MCP tool read_document.